Price $46.65 |
Market Cap
1.76B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
6.31
|
P/S
7.28
|
Dividend %
-
|
|
P/CF
35.8
|
P/FCF
-
|
Op. Cash Flow
-9.2K
|
FCF
-0.3
|
|
Op. Margin
-9.70%
|
Net Margin
-10.10%
|
ROE
-11.40%
|
ROI
-9.30%
|
|
ROA
-8.40%
|
EPS Growth
-626.00%
|
Current Ratio
6.5
|
Debt/Equity
7.70%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| AcelRx Pharmaceuticals Inc (ACRX) | $2.18 | - | - | 123.5M | Strong Buy |
| American Bio Medica Corporatio (ABMC) | $0.22 | - | - | 4.7M | Strong Buy |
| AmerisourceBergen Corp. (ABC) | $106.52 | - | 1.80% | 19.8B | Strong Buy |
| Boston Scientific Corporation (BSX) | $37.03 | - | - | 50.9B | Strong Buy |
| China Pharma Holdings, Inc. (CPHI) | $0.68 | - | - | 19.8M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
